Tebra

Services & Capabilities

Tebra's offer is a software platform with services attached, organised around the main functions of an independent practice.

• Clinical (EHR): electronic health records with charting, e-prescribing and telehealth. AI Note Assist, launched in June 2025, listens during patient visits and generates structured, editable clinical notes in formats including SOAP, therapy and psychiatric notes, and proposes ICD-10 codes.
• Billing and payments: medical billing software and billing support, the heritage of Kareo. In August 2026 Tebra highlighted AI-driven billing tools aimed at denial risk and accounts receivable efficiency, and in September 2026 AI tools for medical claim prioritisation.
• Patient experience: online scheduling, reminders, reviews and reputation management. In October 2025 Tebra launched AI Review Replies and AI Review Insights within its EHR+ Patient Experience package, describing itself as the only EHR software offering native AI sentiment analysis and automated review responses.
• Practice marketing: websites and marketing services for practices, the heritage of PatientPop.

The platform records its service lines as AI & Automation Services; Finance & Accounting; Healthcare Services; Insurance Services; Virtual Assistant.

Integrated partners: Tebra extends the platform through third-party integrations rather than building every function itself. In November 2025 it integrated RxInform, a prescription notification solution from DrFirst, to address medication non-adherence, and it has partnered with WoundZoom on wound care management. In August 2026 FDB extended its ambient AI from documentation to prescribing in the first commercial deployment of Script Agent with Tebra.

Positioning: The breadth of the bundle is the point. A small practice can buy clinical records, billing, payments and marketing from one vendor, which reduces integration work and gives Tebra several revenue lines per customer. The trade-off is that it competes with specialists in each category, from billing services companies to practice marketing agencies, and must keep every module competitive.

Client Base & Market Position

Tebra's market is independent healthcare: small and mid-sized physician practices, mental health clinics and specialty providers, rather than hospitals or large health systems. The company's December 2025 funding release described it as trusted by over 140,000 private healthcare providers with 125M patient records, and its product releases cite more than 42,000 private practices. Outsource Accelerator's directory profile gives an older figure of over 100,000 healthcare providers caring for more than 85 million patients.

Named customers: Tebra's product releases quote practitioners rather than publishing case studies with large enterprise names. Its June 2025 AI Note Assist launch quoted providers from Daisy Family Health Care and Beaumont WELLness for Women, examples of the single-site primary care and women's health practices that make up its base.

Market position: Independent practices have historically been served by technology built for larger systems, a point Hildred's managing partner made in the financing release when he called independent practices the backbone of the U.S. healthcare system and historically underserved by legacy technology. Tebra's pitch is built on that gap. Its own research supports the theme: it reports that 82% of independent providers believe more patient time is their key competitive advantage, which is the benefit its automation tools promise.

Recognition: Tebra was recognised by Software Advice in 2026, and its newsroom lists the award alongside its product launches.

The concentration on small practices is both a strength and a constraint. It gives Tebra a large number of customers and low dependence on any single account, but independent practices are price-sensitive, consolidating into larger groups in many specialties, and quick to switch vendors when billing results disappoint.

Delivery Infrastructure & Operations

Tebra delivers its services through a cloud platform, so its operations are defined by product engineering, customer support and billing teams rather than by delivery centres.

United States: The company's listed office is on Bayside Drive in Corona Del Mar, CA. It operates a hybrid work model with a monthly work-from-home subsidy, and most of its current postings are remote roles in the United States, including a Director of Strategic Finance, a Head of AI Engineering & Enablement and several sales and marketing roles. In September 2026 the Orange County Business Journal reported that Tebra led Orange County software firms in hiring.

Costa Rica: Tebra is also hiring in Costa Rica, with open roles for a Staff Backend Software Engineer in Santa Bárbara, Heredia and a Customer Success Operations Analyst. Costa Rica gives it near-shore engineering and customer success capacity in a US-aligned time zone, a lower-cost alternative to building all teams in California.

Hiring: The platform tracks 23 open roles. The mix of engineering, AI and sales roles reflects the use of the December 2025 financing: building AI features and selling them into its practice base.

Compliance: The platform records HIPAA among its certifications, and Tebra positions its AI review tools as maintaining HIPAA compliance, a basic requirement for any vendor handling patient records.

Ownership, Financials & Scale

Ownership: Tebra is privately held. Its December 2025 financing of $250 million in new equity and debt was led by Hildred and included significant participation from existing investors Toba Capital, Transformation Capital and HLM Venture Partners. J.P. Morgan provided a debt facility.

Financials: No company-published revenue figure was found during research.

Use of capital: Tebra said it would use the funding to deploy AI-powered capabilities across every aspect of practice management, including EHR, billing and payments, patient experience and practice marketing. The combination of equity and a bank debt facility gives the company growth capital without a public listing, while adding debt obligations to its balance sheet.

Scale: Earlier records put the workforce at 760. By customer measures, Tebra cites more than 42,000 private practices and, in December 2025, over 140,000 private healthcare providers and 125M patient records.

People, Leadership & Culture

Leadership: Dan Rodrigues is Tebra's Founder and Chief Executive Officer. He framed the December 2025 financing as a direct mandate to eliminate the squeeze on private practices, tying the company's AI investment to the cost and time pressures on small providers.

Kyle Ryan is Chief Product and Technology Officer and the executive quoted on most of Tebra's AI launches, from AI Note Assist to the DrFirst integration. The platform's recorded leadership also includes Kevin Marasco (Chief Growth Officer), Amanda Piwonka (Chief People Officer), Andrea Weisz (Chief Customer Officer) and Mike Doktorczyk, recorded as Chief Financial Officer. Marasco was Chief Marketing Officer in April 2024, so the growth function has been broadened since the PatientPop brand was retired.

Culture: Tebra lists five values: start with the customer, keep it simple, stay entrepreneurial, better together and celebrate success. Its benefits include stock options, a hybrid work model and 10 paid holidays. It was named to Built In Los Angeles: Best Places to Work 2024 and was named a National Top Workplace for 2023.

Workforce research: In February 2026 Tebra published a report on AI use among healthcare staff, finding that 3 in 5 staff said ChatGPT cut burnout but 14% admitted they could not function emotionally without it, an example of the content marketing it uses to reach practice owners.

Technology & Innovation

Technology is Tebra's product, and AI is the centre of its current roadmap.

EHR+ platform: Tebra connects EHR software, billing, automation, telehealth and marketing in one platform. The integration of two formerly separate companies, Kareo and PatientPop, completed with the retirement of the PatientPop brand in April 2024, gave it a single product to build AI features on.

Ambient documentation: AI Note Assist, launched in June 2025, generates clinical notes from patient visits, and early adopters reported a 50% reduction in note-taking time. In September 2026 Tebra expanded its AI-powered tools for clinical documentation.

AI in prescribing: In August 2026 FDB described its Script Agent deployment with Tebra as the first commercial deployment extending ambient AI from documentation to prescribing. Moving AI from note-taking into medication orders raises the clinical stakes and the need for accuracy controls.

AI in billing and growth: Tebra highlighted AI-driven billing tools targeting denial risk and accounts receivable efficiency in August 2026, and an AI voice assistant to deepen EHR workflow integration the same month. AI Review Replies and AI Review Insights, launched in October 2025, apply sentiment analysis to online reviews.

R&D funding: The $250 million financing in December 2025 was raised to accelerate R&D in AI and automation, and its open roles include a Head of AI Engineering & Enablement. The pace of releases since the financing shows that money being spent on features rather than acquisitions.

Strategic Assessment

Strengths

• Focused market: It builds exclusively for independent practices, with more than 42,000 private practices and over 140,000 providers cited.
• Integrated bundle: EHR, billing, payments, patient experience and marketing in one platform give it several revenue lines per customer.
• Capital: The $250 million equity and debt financing in December 2025 funds AI development.
• AI pace: It has released ambient documentation, AI review tools, billing AI and AI prescribing with FDB since June 2025.

Risks and Vulnerabilities

• Customer base: Small practices are price-sensitive and consolidating into larger groups.
• Clinical AI exposure: Extending AI into clinical notes and prescribing raises accuracy and liability requirements.
• Debt: The J.P. Morgan debt facility adds repayment obligations alongside the equity raise.
• Breadth: It competes with specialists in every module, from billing services firms to practice marketing agencies.

Opportunities

• Billing automation: AI tools for denials and claim prioritisation address the main financial pain point for small practices.
• Partner ecosystem: Integrations with DrFirst, WoundZoom and FDB add capabilities without building them.
• Near-shore capacity: Hiring in Costa Rica gives it lower-cost engineering and customer success teams in a US time zone.